Patenting in Ophthalmology

Mucke HA, Mucke PM: Current drug patenting for retinal diseases: Beyond VEGF inhibitors. IDrugs 13(1): 30-37 (2010) PubMed link

Mucke HAM, Mucke P, Mucke E: International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics. Clin Ophthalmology 3: 103–109 (2009) PubMed linkDownload

Mucke HAM: New ocular therapeutics: a view from the patenting perspective. IDrugs 10(1):37-41 (2007) PubMed link

 

 

 

 

 

 

 

 

 

Browser Bookmark   |  Bookmark at del.icio.usbookmark at digg.combookmark at stumbleupon.comPublish in Twitter

 

H.M. Pharma Consultancy
Head Office
Enenkelstrasse 28/32
A-1160 Vienna, Austria
Ph.: +43 664 101 0121
Fx.: +43 664 77 101 0121
contact


EU Extension Office
A-8443 Gleinstätten 2, Austria
contact

Follow hmpharmacon on TwitterFollow HM Pharmcaon on Blogspot!